Clinical Trial Update: The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism.

View source ↗

Summary

This clinical trial update describes evaluating 68Ga-Pentixafor and 68Ga-FAPI-04 PET/MR imaging for assessing primary aldosteronism; the study is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• 68Ga-FAPI-04
• 68Ga-Pentixafor

Snippet

Sponsor: Shanghai East Hospital | Conditions: Primary Aldosteronism | Status: NOT_YET_RECRUITING